Novartis Managed Care Report Finds Higher Barriers to Drug AccessByFebruary 22nd 2009Higher co-pays, ‘NDC block policies’ and multiple tiers add to drug benefit complexity
Examining the ROI of personalized medicineByFebruary 20th 2009New Deloitte study finds “profound” positive and negative ROIs for combined therapies and diagnostics based on genetics